Sugi Predict

Sugi Predict / Targets / PWWP2B

PWWP2B

PWWP domain-containing protein 2B · Q6NUJ5 · PWWP2B on Sugi Atlas →

0 patent compounds predicted against PWWP2B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PWWP2B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Better Delineation of BCL11B Related Phenotype and Epigenetic Signature. nanCOMPLETED
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures. nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
MRI in Pediatric Inherited Neurodegnerative Changes nanNOT_YET_RECRUITING
Evaluation of Brain Dysfunction in Patients with Duchene Muscular Dystrophy nanNOT_YET_RECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies nanCOMPLETED
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Molecular and Clinical Studies of Primary Immunodeficiency Diseases nanUNKNOWN
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome nanWITHDRAWN
Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking* nanCOMPLETED
Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study nanCOMPLETED
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan nanENROLLING_BY_INVITATION
Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders nanUNKNOWN
A to Z Study Follow-up: Collection of DNA Data From Buccal Swabs nanUNKNOWN
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers nanRECRUITING
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis nanWITHDRAWN
Chromosome 9 P Minus Syndrome nanRECRUITING
I-Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases nanRECRUITING
Personalised Therapeutics @LUMC nanACTIVE_NOT_RECRUITING
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Finding Genes With NGS Techniques in Whom Mutations Cause Neurological Diseases nanUNKNOWN
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PWWP2B binder may also engage these)

ProteinNameSimilarity
E9Q9M8 — 0.998 E9Q9M8 →
Q6PJ61 — 0.990 Q6PJ61 →
Q61127 — 0.986 Q61127 →
Q8BG80 — 0.985 Q8BG80 →
O35615 — 0.985 O35615 →
A2A9T0 — 0.985 A2A9T0 →
Q4KMQ1 — 0.984 Q4KMQ1 →
O14529 — 0.984 O14529 →
P78524 — 0.983 P78524 →
Q96RY5 — 0.983 Q96RY5 →
Q8BSN5 — 0.983 Q8BSN5 →
Q15742 — 0.982 Q15742 →
D4AE48 — 0.982 D4AE48 →
Q9ERQ3 — 0.982 Q9ERQ3 →
Q9NR83 — 0.982 Q9NR83 →
Q8BLS7 — 0.982 Q8BLS7 →
TERF2 Telomeric repeat-binding factor 2 0.982 landscape →
Q6AY75 — 0.982 Q6AY75 →
Q4KLY2 — 0.982 Q4KLY2 →
Q8CD60 — 0.981 Q8CD60 →
Q6PAJ3 — 0.981 Q6PAJ3 →
Q504T8 — 0.981 Q504T8 →
A7YWL5 — 0.981 A7YWL5 →
Q5U5E5 — 0.981 Q5U5E5 →
B0BN13 — 0.980 B0BN13 →
A2AEV7 — 0.980 A2AEV7 →
Q8TF44 — 0.980 Q8TF44 →
Q2M3V2 — 0.980 Q2M3V2 →
Q8NCF5 — 0.980 Q8NCF5 →
Q62925 — 0.980 Q62925 →